Abstract
Phage therapy can be a useful approach in a number of clinical cases associated with multidrug-resistant (MDR) bacterial infections. In this study, we describe a successful consecutive phage and antibiotic application to cure a 3-month-old girl suffering from severe bronchitis after tracheostomy. Bronchitis was associated with two bacterial agents, MDR Pseudomonas aeruginosa and a rare opportunistic pathogen Dolosigranulum pigrum. The phage cocktail “Pyobacteriophage” containing at least two different phages against isolated MDR P. aeruginosa strain was used via inhalation and nasal drops. Topical application of the phage cocktail removed most of P. aeruginosa cells and contributed to a change in the antimicrobial resistance profile of surviving P. aeruginosa cells. As a result, it became possible to choose and administer an appropriate antibiotic that was effective against both infectious agents. Complete recovery of the infant was recorded.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mitropoulou G, Koutsokera A, Csajka C et al (2022) Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations. Eur Respir Rev 31(166):220121. https://doi.org/10.1183/16000617.0121-2022
Law N, Logan C, Yung G et al (2019) Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient. Infection 47:665–668. https://doi.org/10.1007/s15010-019-01319-0
Maddocks S, Fabijan AP, Ho J et al (2019) Bacteriophage therapy of ventilator-associated pneumonia and empyema caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med 200(9):1179–1181. https://doi.org/10.1164/rccm.201904-0839LE
Aslam S, Courtwright AM, Koval C et al (2019) Early clinical experience of bacteriophage therapy in 3 lung transplant recipients. Am J Transplant 19(9):2631–2639. https://doi.org/10.1111/ajt.15503
Lin JC, Hou SJ, Huang LU et al (2006) Acute cholecystitis accompanied by acute pancreatitis potentially caused by Dolosigranulum pigrum. J Clin Microbiol 44(6):2298–2299. https://doi.org/10.1128/JCM.02520-05
Lécuyer H, Audibert J, Bobigny A et al (2007) Dolosigranulum pigrum causing nosocomial pneumonia and septicemia. J Clin Microbiol 45(10):3474–3475. https://doi.org/10.1128/JCM.01373-07
Sherret J, Gajjar B, Ibrahim L et al (2020) Dolosigranulum pigrum: predicting severity of infection. Cureus 12(8):e9770. https://doi.org/10.7759/cureus.9770
Kutter E (2009) Phage host range and efficiency of plating. In: MRJ C, Kropinski AM (eds) Bacteriophages: methods and protocols. Humana Press, pp 141–149
Acknowledgments
This study was supported by the Russian state-funded project for ICBFM SB RAS (grant number 121031300043-8).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Morozova, V.V., Kozlova, Y.N., Tikunova, N.V. (2024). Successful Use of Phage and Antibiotics Therapy for the Eradication of Two Bacterial Pathogens from the Respiratory Tract of an Infant. In: Azeredo, J., Sillankorva, S. (eds) Bacteriophage Therapy. Methods in Molecular Biology, vol 2734. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3523-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3523-0_15
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3522-3
Online ISBN: 978-1-0716-3523-0
eBook Packages: Springer Protocols